US equities
|
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SNDK
$1,238.03
▲+0.00%
SPCX
$147.49
▲+0.00%
NBIS
$158.74
▲+0.00%
NVDA
$210.96
▲+0.00%
AAPL
$347.73
▲+0.00%
NU
$15.16
▲+0.00%
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SNDK
$1,238.03
▲+0.00%
SPCX
$147.49
▲+0.00%
NBIS
$158.74
▲+0.00%
NVDA
$210.96
▲+0.00%
AAPL
$347.73
▲+0.00%
NU
$15.16
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Milestone Pharmaceuticals Inc. - Common Shares
(NQ:
MIST
)
0.6482
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Milestone Pharmaceuticals Inc. - Common Shares
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 14, 2026
From
Milestone Pharmaceuticals Inc.
Via
GlobeNewswire
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Beverage Platform Further Building Shareholder Value – IMG, YCBD, SURG, URG Inside
December 15, 2025
Via
AB Newswire
MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm
January 18, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
January 06, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST
January 04, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
January 01, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST
December 31, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
December 26, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
